drugset / Trial / NCT01536366
Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the CYP2C8 inhibition by BIA 9-1067.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-07
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 25 mg | — |
| Subject | Repaglinide | Small molecule | 0.5 mg | — |